Ponatinib in Philadelphia chromosome-positive leukemias.
Quintas-Cardama, Alfonso
Ponatinib in Philadelphia chromosome-positive leukemias. [electronic resource] - The New England journal of medicine 02 2014 - 577 p. digital
Publication Type: Letter; Comment
1533-4406
10.1056/NEJMc1315234 doi
Female
Humans
Imidazoles--therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Protein Kinase Inhibitors--therapeutic use
Pyridazines--therapeutic use
Thrombosis--chemically induced
Ponatinib in Philadelphia chromosome-positive leukemias. [electronic resource] - The New England journal of medicine 02 2014 - 577 p. digital
Publication Type: Letter; Comment
1533-4406
10.1056/NEJMc1315234 doi
Female
Humans
Imidazoles--therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Protein Kinase Inhibitors--therapeutic use
Pyridazines--therapeutic use
Thrombosis--chemically induced